PFE Im sure there's better days ahead. This stock is really beaten down, though. These past few years definitely hasnt been fun for a lot of holders, but if there's one thing for sure, the rest of the market looks like a straight-up line ready for correction.
PFE Pfizer already picked up Metsera and now pledging $70 B investements in the US, I assume that includes acquisitions. Anyone having thoughts on whether Pfizer will pick up more smaller players like Viking? Is it reasonable to believe that Metsera will be the only leg they have if they truly want a piece of the obesity market?